Minimum ignition energy of medicinal powder – Florfenicol and Tilmicosin (cas 108050-54-0)
-
Add time:08/23/2019 Source:sciencedirect.com
This work aims to help improve the electrostatic safety design and explosion prevention of medical facilities. In this study, the minimum ignition energies (MIEs) of Florfenicol, Tilmicosin and mixtures of Florfenicol and Tilmicosin at ratios of 1:1, 1:2, 2:1 and 1:4 were measured in a Hartmann apparatus. The results demonstrated that the MIEs for Florfenicol, Tilmicosin and mixtures of Florfenicol and Tilmicosin at ratios of 1:1, 1:2, 2:1 and 1:4 are 200, 70, 180, 150, 200 and 110 mJ, respectively. Tilmicosin is more sensitive to static electricity, which is more dangerous than the other two powders examined in this paper. Furthermore, the MIEs of the mixtures are proportional to the Florfenicol content. For all powders, the MIE first decreased with the powder mass and later reached its minimum value. In addition, scanning electron microscopy (SEM), differential scanning calorimetry (DSC) were used to investigate the morphological specificity and thermal decomposition of the powders to elucidate the parameters governing the powder explosions further.
We also recommend Trading Suppliers and Manufacturers of Tilmicosin (cas 108050-54-0). Pls Click Website Link as below: cas 108050-54-0 suppliers
Prev:Preparation and evaluation of Tilmicosin (cas 108050-54-0) microspheres and lung-targeting studies in rabbits
Next:Microbiological toxicity of Tilmicosin (cas 108050-54-0) on human colonic microflora in chemostats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ResearchEffects of Tilmicosin (cas 108050-54-0) Phosphate Administration on Echocardiographic Parameters in Healthy Donkeys (Equus asinus): An Experimental Study08/29/2019
- Effects of nasal instillation of a nitric oxide-releasing solution or parenteral administration of Tilmicosin (cas 108050-54-0) on the nasopharyngeal microbiota of beef feedlot cattle at high-risk of developing respiratory tract disease08/28/2019
- Astragalus polysaccharides alleviate Tilmicosin (cas 108050-54-0)-induced toxicity in rats by inhibiting oxidative damage and modulating the expressions of HSP70, NF-kB and Nrf2/HO-1 pathway08/27/2019
- ResearchEffects of oral Tilmicosin (cas 108050-54-0) on health and performance in newly received beef heifers08/26/2019
- Microstructure and antioxidative capacity of the microalgae mutant Chlorella PY-ZU1 during Tilmicosin (cas 108050-54-0) removal from wastewater under 15% CO208/25/2019
- Microbiological toxicity of Tilmicosin (cas 108050-54-0) on human colonic microflora in chemostats08/24/2019
- Preparation and evaluation of Tilmicosin (cas 108050-54-0) microspheres and lung-targeting studies in rabbits08/22/2019
- Removal of combined antibiotic (florfenicol, tylosin and Tilmicosin (cas 108050-54-0)) during anaerobic digestion and their relative effect08/21/2019


